Data gathered: June 24
AI Stock Analysis - DaVita (DVA)
Analysis generated June 4, 2024. Powered by Chat GPT.
DaVita Inc. is a leading provider of kidney dialysis services. With a mission to provide top-notch quality care for patients with chronic kidney failure or end-stage renal disease, DaVita operates kidney dialysis centers and provides related lab services primarily in the United States. In recent years, they have expanded their operations and focused on integrating innovative healthcare solutions to enhance patient outcomes.
Stock Alerts - DaVita (DVA)
 |
DaVita | June 10 Over the past few months, there has been an upward trend in Web Traffic. |
|
DaVita | May 28 Insider Alert: BUFFETT WARREN E is continuing selling shares |
|
DaVita | May 13 Insider Alert: BUFFETT WARREN E is selling shares |
|
DaVita | May 12 Web Traffic is up by 48.9% over the last month. |
Download our app to get future alerts delivered in real-time.
Alternative Data for DaVita
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 3,936 | Sign up | Sign up | Sign up |
| Sentiment | 95 | Sign up | Sign up | Sign up |
| Webpage traffic | 1,304,000 | Sign up | Sign up | Sign up |
| Employee Rating | 66 | Sign up | Sign up | Sign up |
| Google Trends | 80 | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 1,171 | Sign up | Sign up | Sign up |
| Facebook Followers | 123,876 | Sign up | Sign up | Sign up |
| Instagram Followers | 23,177 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 2 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,192 | Sign up | Sign up | Sign up |
| Twitter Followers | 14,621 | Sign up | Sign up | Sign up |
| Twitter Mentions | N/A | Sign up | Sign up | Sign up |
| Youtube Subscribers | 45,200 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 53 | Sign up | Sign up | Sign up |
| Linkedin Employees | 37,478 | Sign up | Sign up | Sign up |
About DaVita
DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.
| Price | $140.95 |
| Target Price | Sign up |
| Volume | 450,220 |
| Market Cap | $10.3B |
| Year Range | $133.5 - $177.35 |
| Dividend Yield | 0% |
| PE Ratio | 13.59 |
| Analyst Rating | 0% buy |
| Industry | Medical Care Facilities |
In the news
 |
Is DaVita Stock Underperforming the S&P 500?June 23 - Yahoo |
 |
QRG Capital Management Inc. Sells 432 Shares of DaVita Inc. (NYSE:DVA)June 22 - ETF Daily News |
|
Sowell Financial Services LLC Takes Position in DaVita Inc. (NYSE:DVA)June 21 - ETF Daily News |
|
5,528 Shares in DaVita Inc. (NYSE:DVA) Purchased by SG Americas Securities LLCJune 20 - ETF Daily News |
|
Farther Finance Advisors LLC Acquires 713 Shares of DaVita Inc. (NYSE:DVA)June 20 - ETF Daily News |
|
3 Takeaways From DaVita CEO Javier Rodriguez on the Future of Health TechnologyJune 19 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '25 | 3.22B | 2.24B | 984M | 163M | 598M | 2.000 |
| Q4 '24 | 3.29B | 2.23B | 1.07B | 259M | 727M | 2.240 |
| Q3 '24 | 3.26B | 2.15B | 1.11B | 215M | 695M | 2.500 |
| Q2 '24 | 3.19B | 2.14B | 1.04B | 223M | 645M | 2.500 |
| Q1 '24 | 3.07B | 2.08B | 992M | 240M | 629M | 2.260 |
Insider Transactions View All
| BUFFETT WARREN E filed to sell 33,796,541 shares at $140.2. May 27 '25 |
| BUFFETT WARREN E filed to sell 33,880,485 shares at $138.6. May 27 '25 |
| BUFFETT WARREN E filed to sell 33,808,519 shares at $139.6. May 27 '25 |
| BUFFETT WARREN E filed to sell 33,899,815 shares at $138.6. May 27 '25 |
| BUFFETT WARREN E filed to sell 33,936,709 shares at $137.3. May 27 '25 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Gerald Moran Republican |
Jan 17, 24 | Sell | $1K - $15K |
| Gerald Moran Republican |
Jan 17, 24 | Sell | $1K - $15K |
| Thomas Tuberville Republican |
Jan 12, 24 | Sell | $1K - $15K |
Read more about DaVita (DVA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of DaVita?
The Market Cap of DaVita is $10.3B.
What is DaVita's PE Ratio?
As of today, DaVita's PE (Price to Earnings) ratio is 13.59.
What is the current stock price of DaVita?
Currently, the price of one share of DaVita stock is $140.95.
How can I analyze the DVA stock price chart for investment decisions?
The DVA stock price chart above provides a comprehensive visual representation of DaVita's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling DaVita shares. Our platform offers an up-to-date DVA stock price chart, along with technical data analysis and alternative data insights.
Does DVA offer dividends to its shareholders?
As of our latest update, DaVita (DVA) does not offer dividends to its shareholders. Investors interested in DaVita should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of DaVita?
Some of the similar stocks of DaVita are Encompass Health, Brookdale Senior Living, Amedisys, Tenet Healthcare, and Encompass Health.
.